GD Giovanni, VD Matteo, M Pierucci… - Current topics in …, 2006 - ingentaconnect.com
Since the 1950s, when serotonin (5-HT) was discovered in the mammalian central nervous system (CNS), an enormous amount of experimental evidence has revealed the pivotal role …
E Mohr, T Mendis, K Hildebrand… - … : Official Journal of the …, 2000 - Wiley Online Library
PURPOSE To evaluate the safety and efficacy of risperidone in patients with Parkinson's disease (PD) who are experiencing significant dopamine‐induced psychosis. PATIENTS …
A Di Stefano, P Sozio, LS Cerasa - Molecules, 2008 - mdpi.com
Parkinson's disease (PD) is a progressive, neurodegenerative disorder which involves the loss of dopaminergic neurons of the substantia nigra pars compacta. Current therapy is …
K Radhakrishnan, P Senthil Kumar, G Rangasamy… - Applied …, 2023 - Springer
Nanotechnology is an emerging field that is useful for various purposes. Numerous neurological disorders, such as Parkinson's disease (PD), Alzheimer's disease (AD), stroke …
A Di Stefano, P Sozio… - Current …, 2011 - ingentaconnect.com
L-Dopa is the mainstay of Parkinson's disease therapy; this drug is usually administered orally, but it is extensively metabolized in the gastrointestinal tract, so that relatively little …
P Barili, G De Carolis, D Zaccheo, F Amenta - Mechanisms of ageing and …, 1998 - Elsevier
The limbic system includes the complex of brain centres, nuclei and connections that provide the anatomical substrate for emotions. Although the presence of small amounts of …
W Li, DT Rossi, ST Fountain - Journal of pharmaceutical and biomedical …, 2000 - Elsevier
A semi-automated alumina-based extraction method for the determination of l-dopa and dopamine in plasma using liquid chromatography/mass spectrometry was validated. The …
RAJ Crans, E Wouters, M Valle-León, J Taura… - Frontiers in …, 2020 - frontiersin.org
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor control deficits, which is associated with the loss of striatal dopaminergic neurons from the …
Background: When levodopa therapy is used in Parkinson's disease, degradation of the drug in the peripheral nervous system is associated with dyskinesias and motor fluctuations …